Drug Development

Articles

Also, Genzyme to build R&D center in Beijing, Noven Pharmaceuticals appoints Peter C. Brandt president and CEO, more...

Company and People Notes: GSK to Acquire Sirtris, Alfacell's CEO and Scientific Founder to Retire, More

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

The US House of Representatives Energy and Commerce Committee is proposing legislation to address the funding and authority of the US Food and Drug Administration in regulating the safety of the country's drug supply.

Congress Moves to Improve FDA's Inspection Process

Ell Lilly plans to streamline a portion of its manufacturing operations in Indianapolis.

Eli Lilly to Streamline Manufacturing in Indianapolis

Also, GSK expands in Ireland, executive appointments at ProGenTech, more...

Company and People Notes: FDA Warns Puerto Rico-Based Compounder Farmacia La Salud, Chemokine Names Walter Korz President and CEO, More

Angie Drakulich was editorial director of Pharmaceutical Technology.

The US Food and Drug Administration issued a final guidance last week regarding investigational new drug applications for human gene therapy.

Gene Therapy CMC Guidance Released

Dave Drew, group pharmaceutical director of Matcon (Moreton-in-Marsh, UK), says that lean production is essential for drugmakers to survive in the current environment.

Lean Manufacturing Begins with Efficient Material Handling

Takeda Pharmaceutical agreed to acquire Millennium Pharmaceuticals for $8.8 billion in cash or $25 per share.

Takeda to Acquire Millennium for $8.8 Billion

Also, Alcon plans to open Singapore facility, Pharmacopeia president and CEO retired, more...

Company and People Notes: Roche to Acquire Piramed for $160 Million, Adventrx Pharma Appoints Jose Hechavarria VP of Manufacturing, More

Also, Jubilant Organosys to acquire DRAXIS Health, PPD's Paul Covington to retire, more...

Company and People Notes: Novartis to Acquire A Majority Ownership of Alcon, Alba Therapeutics Appoints Bruce A. Peacock CEO, More

Schering-Plough announced a major new productivity transformation program with a goal of achieving $1.5 billion in annual savings.

Ingredients